Publication | Open Access
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma
16
Citations
30
References
2023
Year
These findings encourage further development of NK-92/5.28.z cells as off-the-shelf immunotherapy for the treatment of metastatic RMS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1